Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple Sclerosis

The number of ageing people with relapsing multiple sclerosis (RMS) is increasing. The efficacy of disease-modifying therapies (DMTs) for RMS declines with age. Also, older persons with MS may be more susceptible to infections, hospitalisations and malignancy. Aging people with MS have higher rates...

Celý popis

Podrobná bibliografia

Vydané v:	Neurology and therapy Ročník 13; číslo 3; s. 519 - 533
Hlavní autori:	de Seze, Jerome, Dive, Dominique, Ayrignac, Xavier, Castelnovo, Giovanni, Payet, Marianne, Rayah, Amel, Gobbi, Claudio, Vermersch, Patrick, Zecca, Chiara
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Cheshire Springer Healthcare 01.06.2024 Adis, Springer Healthcare
Edícia:	Neurology and Therapy
Predmet:	Ageing Cladribine tablets Disease-modifying therapy Internal Medicine Life Sciences Medicine Medicine & Public Health Neurology Relapsing multiple sclerosis Review Relapsing multiple sclerosis Cladribine tablets Disease-modifying therapy Ageing
ISSN:	2193-8253, 2193-6536
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!